Division of Occupational and Environmental Medicine, Lund University, Lund, Sweden.
Department of Obstetrics and Gynecology, Institute of Clinical Sciences Lund, Lund University, Lund, Sweden.
PLoS One. 2023 Feb 7;18(2):e0281234. doi: 10.1371/journal.pone.0281234. eCollection 2023.
Preeclampsia is considered a major cause of maternal and fetal morbidity and mortality. The aim of the present case-control study in Sweden was to assess the hypothesized association between low serum vitamin D concentrations in early pregnancy and the risk of developing preeclampsia since vitamin D may play a role in early placental development.
The study included 296 women diagnosed with preeclampsia (cases) and 580 healthy pregnant women (controls). Serum samples were obtained from a biobank of samples collected in early pregnancy including almost all pregnancies in Southern Sweden. Concentrations of 25-hydroxyvitamin D3 (vitamin D) were analyzed using liquid chromatography-tandem-mass-spectrometry (LC/MS/MS). The cases were divided into two categories: i) infants were born before gestational week 34 (early onset) and/or born small-for-gestational age (SGA)(n = 51), ii) and others defined as late onset (n = 245). Vitamin D concentrations were analyzed both as a continuous and a categorized variable.
When all preeclampsia cases were included in the analyses no consistent patterns were observed. However, the median serum concentrations of vitamin D were significantly lower among the cases who were early onset and/or were born SGA (median 39.2 nmol/L, range 1.2-93.6) as compared to the controls (49.0 nmol/L, 0.1-219; p = 0.01). In addition, high concentrations were statistically significantly associated with a decreased risk of preeclampsia (>66.9 vs ≤30.1 nmol/L; crude OR 0.39, 95% CI 0.16-0.96). When potential confounders were included in the models the associations were even more pronounced.
Our results support the hypothesis that vitamin D deficiency is a risk factor for preeclampsia, but only in preeclampsia cases who were early-onset and/or were born SGA. Preeclampsia is not a homogenous condition and more studies are needed before vitamin D supplementation during pregnancy can be recommended.
子痫前期被认为是孕产妇和胎儿发病率和死亡率的主要原因。本研究在瑞典进行了病例对照研究,旨在评估早期妊娠时低血清维生素 D 浓度与子痫前期发病风险之间的假设关联,因为维生素 D 可能在早期胎盘发育中发挥作用。
研究纳入了 296 例子痫前期患者(病例)和 580 例健康孕妇(对照)。血清样本取自瑞典南部早期妊娠生物样本库,几乎包含了所有的妊娠样本。采用液相色谱-串联质谱法(LC/MS/MS)分析 25-羟维生素 D3(维生素 D)的浓度。病例分为两类:i)婴儿在妊娠 34 周前(早发)和/或出生体重小于胎龄(SGA)(n = 51),ii)其他定义为晚发(n = 245)。维生素 D 浓度分析采用连续变量和分类变量两种方式。
所有子痫前期病例纳入分析时,未观察到一致的模式。然而,早发和/或 SGA 的子痫前期病例的血清维生素 D 中位数明显低于对照组(中位数 39.2 nmol/L,范围 1.2-93.6),而对照组为 49.0 nmol/L,范围 0.1-219(p = 0.01)。此外,高浓度与子痫前期风险降低呈统计学显著相关(>66.9 比 ≤30.1 nmol/L;未校正 OR 0.39,95%CI 0.16-0.96)。纳入潜在混杂因素后,相关性更加显著。
我们的结果支持维生素 D 缺乏是子痫前期的危险因素的假设,但仅适用于早发和/或 SGA 的子痫前期病例。子痫前期不是一种同质的疾病,在推荐孕妇补充维生素 D 之前,还需要进行更多的研究。